Merck and Co.’s (MRK) Vytorin is a cholesterol medicine that blocks the absorption of cholesterol from food and reduces the cholesterol the patient’s body naturally produces. Vytorin is a combination ...

TRENTON (AP) - Results of a preliminary analysis of the just-completed study showed Vytorin, marketed jointly by Merck & Co. and Schering-Plough Corp., was no better than placebo at lowering the risk ...

In what may be an anticlimatic end to a controversy that has hovered over the Vytorin cholesterol pill, an FDA medical reviewer is endorsing the largely positive findings of a study that indicates the ...

Keith Aaronson treats some of the sickest heart patients at the University of Michigan. His patients' heart muscles are failing, and some require transplants. He used to give Zetia to those at high ...

What would a new year be without a full-blown pharmaceutical controversy? Last summer there were black-box warnings for Avandia and Actos, two diabetes drugs associated with heart failure. In the fall ...

You've heard the commercial: "Cholesterol comes from two sources." And it looks like Vytorin's problems are coming from two sources as well, CBS News correspondent Susan Koeppen reports. First, from ...

First Study to Show Statin + Non-Statin Combo Having Clinical Benefit Merck announced that the FDA has approved updated labeling for Vytorin (ezetimibe/simvastatin). SHARP demonstrated that treatment ...

NEW ORLEANS (Reuters) - Researchers attempted on Wednesday to calm concerns about the potential cancer risks of cholesterol fighters Vytorin and Zetia, while others urged caution in prescribing the ...

January 9, 2009 (Rockville, Maryland) — The Food and Drug Administration issued a statement reaffirming its position that lower remains better when it comes to LDL-cholesterol levels and that patients ...

After nearly two years of waiting, the results came out on Monday on the long-awaited heart drug Vytorin — and the news wasn’t good. Vytorin’s manufacturers, Merck and Schering-Plough, announced that ...